South San Francisco, CA
Frontier Medicines’is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins, making them accessible to small-molecule drug discovery and development, enabling patients to consume breakthrough medicines that redefine the course of debilitating diseases.
frontiermeds.comThese are collections Frontier Medicines is a part of. Click on the collection name to view similar companies.
Series C
$20,000,000
Series C
$80,000,000
Series B
$88,500,000
Series A
$67,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Frontier Medicines.